Product categories
Methylene blue is not a supplement; cordyceps is not peptide therapy
Low-dose oral methylene blue appears in focus, energy, and longevity conversations, but methylene blue also has FDA-approved medical contexts and clinically important interaction warnings. Cordyceps refers to fungal products sold as dietary supplements and often marketed for stamina, recovery, immunity, breathing, or healthy aging. The useful comparison is not which ingredient sounds more “mitochondrial” or “natural.” It is whether either category fits the symptom, evidence level, medical history, medication list, product source, and follow-up plan.
- Peptide12 lists low-dose oral methylene blue in its longevity category, but it is not a peptide and should not be marketed as a guaranteed focus, fatigue, depression, ADHD, detox, or anti-aging treatment.
- Cordyceps products can differ by fungal species, fruiting body or mycelium source, extract, serving size, other mushrooms, caffeine, stimulants, fillers, testing, and claims.
- New or worsening fatigue, weakness, shortness of breath, chest symptoms, fainting, palpitations, anemia symptoms, sleep problems, unexplained weight change, infection symptoms, or neurologic changes should be evaluated rather than covered with a stack.